To compare the outcome of infants with respiratory distress syndrome (RDS) in the neonatal intensive care unit (NICU) who were extubated to synchronized nasal intermittent positive pressure ventilation (SNIPPV) or continued on conventional ventilation (CV), immediately postsurfactant.
INTRODUCTION
Respiratory distress syndrome (RDS) and its sequelae, bronchopulmonary dysplasia (BPD) are both frequent complications of prematurity, and account for 21% of infant deaths each year due to complications of prematurity. 1 The overall incidence of BPD in premature infants treated for RDS is 41%. 2 The pathogenesis of BPD is hypothesized to be multifactorial. 3 Sepsis in utero, in addition to ventilator-induced injury and hyperoxia, initiates an inflammatory cascade, which acts on the immature lung. 3 Inflammation interferes with the normal anatomic development of airway and alveoli, and abnormal healing in the premature infant due to immaturity further exacerbates lung tissue damage, resulting in BPD. 3 In an effort to decrease ventilator-induced lung injury, alternative techniques of ventilation have been employed. [4] [5] [6] [7] Recent studies have shown limited or no difference in outcomes when these methods have been used as a primary mode of ventilation for infants with RDS. [5] [6] [7] This has led to suggestions for a noninvasive approach to the ventilation of the newborn with RDS. 7, 8 While use of nasal continuous positive airway pressure (NCPAP) postsurfactant has met with some success, [9] [10] [11] [12] there are infants who have failed that approach.
Nasal intermittent positive pressure ventilation (NIPPV) involves giving continuous positive airway pressure (CPAP) to the infant in the intermittent mandatory ventilation (IMV) mode. We, 8 and others, 13, 14 have advocated the use of synchronized NIPPV (SNIPPV) as a means to wean infants from mechanical ventilation. We have found SNIPPV more effective than NCPAP in weaning infants with RDS from mechanical ventilation and have recommended that SNIPPV be used as the modality of choice for extubation. 8 In our previous study, we also noted a decrease in BPD and retinopathy of prematurity (ROP). In view of benefits noted when SNIPPV was used in the secondary mode (i.e., for extubation after a prolonged weaning phase of mechanical ventilation in the ''recovery'' phase of RDS), we hypothesized that SNIPPV use in the primary mode (i.e., in the ''acute'' phase of RDS) would be safe and useful in preterm infants. As a first step towards the use of SNIPPV as a primary mode of ventilation, we decided to conduct a prospective observational pilot study to compare the outcome of infants with RDS who, immediately after surfactant administration, were continued on conventional ventilation (CV) or were extubated to SNIPPV.
MATERIALS AND METHODS Materials
We used nasopharyngeal prongs (V-SILt binasal airway, 3.0 mm outer diameter, attached to the infant's cheeks by a Neobart; Neotech Products Inc., Chatsworth, CA) for the babies in the SNIPPV group (primary mode). For infants in the CV group, infants were extubated to nasal prongs to provide SNIPPV (secondary mode). The CPAP kit (Argylet CPAP Nasal Cannula Kit; Sherwood Medical, St. Louis, MO) was used for this purpose. The size of the prongs to be used for each infant was determined by their weight as follows: large F for infants weighing >1500 g, and small F for infants 1000 to 1500 g.
The ventilators used were either the Bear Cub (Model BP 2001; Bear Medical Systems, Inc., Riverside, CA) or the Infant Star 500/ 950 (Infrasonics, Inc., San Diego, CA), for infants in the CV group. The Infant Star with the synchronized IMV box (Star Sync; Infrasonics, Inc., San Diego, CA) was used in the infants assigned to SNIPPV primary or secondary modes.
Methods

Subjects.
Consecutively born neonates (28 to 34 weeks of gestation) admitted to the neonatal intensive care unit (NICU) at Albert Einstein Medical Center with the diagnosis of RDS and requiring surfactant administration and mechanical ventilation formed the study group. Infants small for gestational age (GA), or with proven early-onset sepsis or major congenital malformations were excluded. Approval for this observational study was obtained from the Institutional Review Board of the Albert Einstein Healthcare Network. Data were collected as per definitions mentioned below.
Definitions. Pregnancy-induced hypertension (PIH) was defined as a maternal systolic blood pressure of >140 mmHg and a diastolic pressure of >90 mmHg in the presence of proteinuria (>300 mg/24 hours) and nondependent edema. Chorioamnionitis was defined as a positive culture from the amniotic fluid or in the absence of the above, in the presence of organisms on Gram stain, sheets of leukocytes or low glucose in the amniotic fluid in the presence of any two of the following clinical symptomatology, maternal fever, leukocytosis, uterine tenderness, pus from the cervix, and fetal tachycardia. RDS was defined in the presence of respiratory distress and a characteristic chest X-ray (reticulargranular pattern with air bronchograms and low lung volumes). Air leaks were documented by radiographic evidence of pneumothorax, pneumomediastinum or pulmonary interstitial emphysema. Oxygenation index (OI) was defined as the product of the mean airway pressure (MAP) and the fraction of inspired oxygen (FiO 2 ) multiplied by 100 and then divided by the partial pressure of oxygen in the arterial blood (PaO 2 ). Patent ductus arteriosus (PDA) was documented by echocardiography. Intraventricular hemorrhage (IVH) was determined according to Papile's classification of blood in the germinal matrix or ventricular system with or without ventricular dilatation and parenchymal extension. 15 Periventricular leukomalacia (PVL) was defined as cerebral ultrasound findings of increased echogenicity and cystic lesions in the periventricular white matter. 16 BPD was defined as the need for oxygen supplementation at 36 weeks corrected GA in association with characteristic X-ray changes. 17 Sepsis was diagnosed by a positive blood culture. Necrotizing enterocolitis (NEC) was defined as Z stage 2 as per modified Bells criteria. 18 ROP was defined as per the international classification. or to continue with CV was at the attending neonatologist's discretion. All infants were started on aminophylline within the first 24 hours of life. For the CV group, the infant was weaned as clinically indicated and monitored by serial blood gas analyses (see below). The criteria for extubation were PIPr16 cmH 2 O, PEEPr5 cmH 2 O, IMV rate 15 to 25, FiO 2 r0.35. Infants were extubated to SNIPPV (secondary mode) which became standard practice in our NICU following our previous study. 8 Infants in the SNIPPV group were extubated to SNIPPV (primary mode) soon after surfactant administration. Babies extubated to SNIPPV received synchronized IMV at the same rate as they were receiving prior to extubation, PIP was increased by 2 to 4 cmH 2 O while the PEEP was kept r5 cmH 2 O. FiO 2 was adjusted to maintain oxygen saturations 90 to 96% on pulse oximetry. The flow rate was kept at 8 to 10 l/minute.
In both groups, blood gas analyses were conducted, as clinically indicated, from samples obtained from indwelling arterial lines or arterialized capillary blood obtained from a warmed heel. Ventilator settings were adjusted to maintain blood gas parameters as follows: pH 7.25 to 7.45; PaCO 2 40 to 55 mmHg; PaO 2 50 to 80 mmHg. Ventilator settings could be increased or decreased in the SNIPPV mode, if needed, to maintain the target blood gases.
After careful evaluation of the infant's respiratory status, the infant was subsequently weaned from SNIPPV (in both groups) to NCPAP, nasal cannula or oxyhood. This was conducted by the attending neonatologist once the infants had ventilator settings of PIP/PEEP 14/4 cmH 2 O, rate of r20/minute and FiO 2 r0.3 with normal blood gases. Once the child was on NCPAP 4 cmH 2 O or nasal cannula flow of 1 l/minute or in the oxyhood, the FiO 2 was weaned to room air while maintaining oxygen saturations 90 to 96% on pulse oximetry with normal blood gases.
Reintubation was performed in the presence of any of the following: a pH<7.25, PaCO 2 >60 mmHg, a single episode of apnea needing bag and mask resuscitation, frequent (>2 to 3/hour) apnea/bradycardia spells (cessation of respiration for >20 seconds associated with a heart rate <100/minute) on therapeutic serum aminophylline levels; frequent desaturations (< 85%) Z3 episodes/hour not responding to increased ventilatory settings or an increase in FiO 2 to 1.0, or a PaO 2 <50 mmHg despite an FiO 2 of 1.0.
Parenteral nutrition was started in babies in both groups, within the first 24 hours of life, with dextrose and amino acid solutions. Lipids were added on day 2 at 0.5 g/kg/day. Protein and lipids were increased by 0.5 g/kg/day every 24 hours till a maximum of 3 g/kg/ day was achieved. Babies were started on trophic feeds, when clinically stable, and then regular feeds were increased by 10-20% every day, as tolerated. Fluid intake was optimized to 140-160 ml/kg/day by a week of life.
Infants were monitored as per standard NICU nursing protocols. Cranial ultrasounds were conducted on all infants at days 1 to 3, 7 to 10, at discharge, and as indicated. X-rays, cardiac echocardiography, and blood cultures were conducted when clinically indicated. Eye examinations were performed on the infants by pediatric ophthalmologists at 4 to 6 weeks of age and repeated every 1 to 2 weeks as indicated. Specialist physicians performing the cranial ultrasound, echocardiographic and eye examinations were not aware of the child's grouping status. The rest of the medical management of these babies was as per the attending neonatologist.
Discharge criteria for the infants in both groups were uniform and included the ability to maintain their temperature in a crib, apnea-free for 1 week (off aminophylline) with a normal pneumocardiogram, accepting feeds orally and maintaining weight gain, and free from any active infection. No specific GA and/or weight limitations were used to dictate the decision to discharge any infant.
Statistical Analysis
Since these were relatively bigger preterm infants, we felt that BPD would not be an appropriate outcome measure. We selected duration of hospitalization based on our initial analysis 20 and performed a sample size calculation so that the study would have adequate power. To detect a 30% decrease in length of hospitalization with the use of SNIPPV as a primary mode of ventilation, with an a of 0.05 and power of 0.80, 25 babies in each group were needed. SNIPPV and CV groups were compared using Student's t-test, w 2 , Mann-Whitney U or repeated measures ANOVA analyses, as appropriate. Statistical analyses were performed using SPSS 9.0 for Windows (SPSS, Inc., Chicago, IL). A p-value of <0.05 was considered statistically significant.
RESULTS
Between October 1999 and December 2002, 104 infants with a GA of 28 to 34 weeks were consecutively admitted to the NICU. A total of 65 babies (63%) had clinical and radiographic evidence of RDS severe enough to require intubation for surfactant therapy. Of these 65, six babies were excluded; three were small for GA, two had blood culture proven early-onset sepsis, while one had a major congenital anomaly (jejunal atresia). Data were collected from the remaining 59 (57%) infants. After receiving surfactant, 24 (23%) babies were extubated to SNIPPV (primary mode) and 35 (34%) continued on CV. The maternal demographics in these infants were similar as shown in Table 1 .
The birth weight (BW) and GA were similar in both groups (Table 2 ). Prior to surfactant administration, the OI were similar in both groups ( Table 2 ). The median time to extubation to SNIPPV (primary mode) after surfactant administration in the SNIPPV group was 43 minutes. The total duration of endotracheal intubation and duration of supplemental oxygen exposure were significantly shorter in the SNIPPV group (Table 2) . Furthermore, the duration of parenteral nutrition and length of stay were also significantly shorter in the SNIPPV group (Table 2 ). There were no differences in the blood gases or OI at 1, 6, 24 and 48 hours postsurfactant in the 2 groups (Figure 1 ). There was no statistical difference in the incidence of IVH grade I ( Table 2) . None of the infants developed PDA, air leaks, NEC, PVL, late-onset sepsis, ROP or BPD in either group. No infant died in either group.
There were no differences in apnea and/or bradycardia episodes between the two groups of babies throughout their duration of stay in the NICU (data not shown). One infant (1/24, 4%) in the SNIPPV group required reintubation secondary to desaturations and apnea. The infant was found to have a mucus plug near the tracheal inlet and the attending neonatologist elected to keep the infant intubated. The infant was successfully extubated 4 days later to nasal cannula. Once extubated, no baby in the CV group required reintubation.
DISCUSSION
With increased survival of very low birth weight (VLBW) infants, there is renewed interest in minimizing the need for prolonged mechanical ventilation in order to reduce ventilator-induced trauma and oxygen toxicity. Specifically, there has been renewed interest in the use of noninvasive ventilation in the management of these infants. NCPAP has been advocated 9-12 but has not achieved equivalent success in the hands of all investigators. Our attempts to use NCPAP as a primary mode of ventilation led to limited success as infants continued to have apneic/bradycardic episodes and/or significant respiratory failure, based on clinical and blood gas parameters. Given the potential benefits of avoidance of endotracheal intubation, namely, decreased laryngeal and tracheal injury, decreased incidence and severity of BPD and decreased nosocomial pneumonia and sepsis, 14, 21, 22 we decided to utilize SNIPPV as an alternative mode of ventilation. We have previously shown that SNIPPV is significantly better than NCPAP as a mode of extubation in recovering infants with RDS. 8 As a result of that study, 8 SNIPPV was established as the preferred method for extubation in infants recovering from RDS at our institution. The efficacy and safety of this technique has also been reported by others 13, 14, 23 and has been shown to be effective when introduced into a NICU setting where it was previously not in use. 24 We wanted to evaluate the feasibility of using this technique in the larger premature infant in the acute phase of RDS. This paper describes that evaluation and demonstrates that infants 28 to 34 weeks of gestation with RDS with the use of SNIPPV as a primary mode of ventilation had a shorter duration of intubation, decreased need for supplemental oxygen, and decreased length of hospitalization. Furthermore, infants in the SNIPPV group had an earlier achievement of full enteral feeds (as reflected in their significantly shorter duration of parenteral nutrition), compared to infants in the CV group ( Table 2 ). The study patients were well matched in terms of maternal demographics, BW, GA, severity of RDS (as evaluated by OI presurfactant and surfactant doses) as shown in Tables 1 and 2 . There were no significant differences in the OI or blood gas values pre-and postsurfactant as shown in Figure 1 .
It is important to note that there was no difference in the duration of SNIPPV (secondary mode), NCPAP or nasal cannula support between the two groups (Table 2 ). However, there was significantly reduced need for oxygen in the SNIPPV group. This suggests that, given the initial similar gestational maturity and respiratory illness severity in the two groups, infants in the SNIPPV group were able to recover from their lung disease faster. We speculate that infants who were in the SNIPPV group had decreased ventilator-induced lung injury (because of the absence of the endotracheal tube) and hence had a quicker recovery from their lung disease. This improvement in the SNIPPV group infants' respiratory status prompted a quicker advance to full feeds (as evidenced by decreased duration of parenteral nutrition) and earlier discharge from the NICU.
Recently, Kiciman et al. 25 have shown a decrease in thoracoabdominal motion asynchrony in newborn ventilated with nasal IMV, and that nasal IMV decreased flow resistance through the nasal prongs and improved the stability of the chest wall, resulting in improved pulmonary mechanics. We support the notion that the addition of a PIP above PEEP by using SNIPPV not only adds intermittent distending pressure above PEEP, but also increases flow delivery in the upper airway as suggested by Friedlich et al. 13 Furthermore, Moretti et al. 26 found that application of SNIPPV was associated with an increase in tidal and minute volumes as compared to NCPAP in the same infant. Furthermore, SNIPPV could be creating an inadvertent PEEP that would allow further recruitment of alveoli and higher functional residual capacity (FRC).
The major limitation of this study is that it is not randomized. This would potentially allow for bias in allocating patients to the two groups. While some attending neonatologists did have a preference to use SNIPPV over CV, it is important to note, that all the attending neonatologists had at least some infants extubated to SNIPPV as a primary mode. The argument that it would be possible to enter a patient who appears to be doing well into the SNIPPV group, while one who appears sicker, to the CV group is a valid but moot point as the infants in the two groups were well-matched, not only by maternal and infant demographics (Tables 1 and 2 ) but also in their initial respiratory profile (Table 2) , suggesting similar illness severity. Furthermore, the management of RDS for the CV group was fairly consistent in our NICU with standardized guidelines for initiating mechanical ventilation, administration of surfactant, weaning on the ventilator, extubation to SNIPPV (secondary mode), further weaning to NCPAP/oxyhood/nasal cannula, and indications for reintubation, if required. Furthermore, NICU feeding guidelines and discharge criteria were fairly uniformly adhered to by all the attending neonatologists. For the babies in the SNIPPV group, the only difference was the timing of getting to SNIPPV. The infants were switched to the primary mode of SNIPPV, immediately after surfactant administration. The guidelines for further management of these infants remained the same as in the CV group. Since one of the four attending neonatologists was on clinical service for a month at a stretch but would be on call every fourth night (and weekend), the continuing care of the infant was fairly uniform (with input from all the four attending neonatologists) during the infant's stay in the NICU. Hence, we believe that the differences in outcome in the SNIPPV and CV groups accurately reflect the fact that the infants in the former group were extubated to SNIPPV earlier than those in the CV group. To prove a causal relationship relating SNIPPV to less ventilator-induced lung injury and faster recovery in infants with RDS, rather than an association that we have shown in this study, a randomized controlled trial, preferably inclusive of infants of a younger GA and incorporating assessment of pulmonary functions and lung injury, will be needed.
In conclusion, in this pilot observational study, we found that SNIPPV was effective as a primary mode of ventilation in a group of larger premature infants with RDS. A prospective randomized controlled trial of SNIPPV as a primary mode of ventilation is needed in VLBW infants with RDS to assess if such an approach can make an impact on BPD.
